Clinical trial
Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients
NCT04472390 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 3, 2019
- Completion date
- December 31, 2021
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis